Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Eva Nabulime"'
Autor:
Brian Nyiro, Sharon Bright Amanya, Alice Bayiyana, Francis Wasswa, Eva Nabulime, Alex Kayongo, Immaculate Nankya, Gerald Mboowa, David Patrick Kateete, Obondo James Sande
Publikováno v:
Retrovirology, Vol 20, Iss 1, Pp 1-7 (2023)
Abstract Background Several mechanisms including reduced CCR5 expression, protective HLA, viral restriction factors, broadly neutralizing antibodies, and more efficient T-cell responses, have been reported to account for HIV control among HIV control
Externí odkaz:
https://doaj.org/article/d404b6fb29e3407e8c1284220d7f36ce
Autor:
Sharon Bright Amanya, Brian Nyiro, Francis Waswa, Bonniface Obura, Rebecca Nakaziba, Eva Nabulime, Ashaba Fred Katabazi, Rose Nabatanzi, Alice Bayiyana, Gerald Mboowa, Alex Kayongo, Misaki Wayengera, Obondo J. Sande
Publikováno v:
Retrovirology, Vol 17, Iss 1, Pp 1-11 (2020)
Abstract Background Tripartite Motif Containing 5 alpha (TRIM5α), a restriction factor produced ubiquitously in cells and tissues of the body plays an important role in the immune response against HIV. TRIM5α targets the HIV capsid for proteosomal
Externí odkaz:
https://doaj.org/article/a864757a0df4450a98f3dec5a3367f86
Autor:
Alisen Ayitewala, Fred Kyeyune, Pamela Ainembabazi, Eva Nabulime, Charles Drago Kato, Immaculate Nankya
Publikováno v:
AIDS Research and Therapy, Vol 17, Iss 1, Pp 1-9 (2020)
Abstract Background Resistance to antiretroviral drugs is a major challenge among Human Immunodeficiency Virus (HIV) positive patients receiving antiretroviral therapy (ART). Mutations that arise as a result of this are diverse across the various dru
Externí odkaz:
https://doaj.org/article/8709b14c50784b259fd11fe92cae713b
Autor:
Richard M. Gibson, Gabrielle Nickel, Michael Crawford, Fred Kyeyune, Colin Venner, Immaculate Nankya, Eva Nabulime, Emmanuel Ndashimye, Art F. Y. Poon, Robert A. Salata, Cissy Kityo, Peter Mugyenyi, Miguel E. Quiñones-Mateu, Eric J. Arts
Publikováno v:
Infectious Diseases of Poverty, Vol 6, Iss 1, Pp 1-13 (2017)
Abstract Background Thymidine analogs, namely AZT (Zidovudine or Retrovir™) and d4T (Stavudine or Zerit™) are antiretroviral drugs still employed in over 75% of first line combination antiretroviral therapy (cART) in Kampala, Uganda despite avers
Externí odkaz:
https://doaj.org/article/cc1b3016e85046149eaa13ef73e04de9
Autor:
Daniel Karara, Bernard S. Bagaya, Fred Kyeyune, Eva Nabulime, Pamela Ainembabazi, Diana Rutebarika, Roy C. Basiimwa, Paul Arikod, Christine Matama, Immaculate Nankya
IntroductionBy Sept 2018, only 59.3% of all HIV positive children on cART under 5 years were achieving virological suppression compared to 88.4% in the general population in Uganda. CCR5 promoter genotype specifically single nucleotide polymorphisms
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2930efdb087d3e62b3c8b615e94cb6ba
https://doi.org/10.21203/rs.3.rs-1715907/v1
https://doi.org/10.21203/rs.3.rs-1715907/v1
Objective To determine the prevalence of multi-drug resistant variants among patients failing on a nucleoside reverse transcriptase inhibitor (NRTI) based regimen with a detectable viral load ≥ 1000 copies/ml among patients harboring HIV subtype A,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::42e1495c8bb3467a7d4bb8737d45affd
https://doi.org/10.21203/rs.3.rs-666492/v1
https://doi.org/10.21203/rs.3.rs-666492/v1
Autor:
Gerald Mboowa, Bonniface Obura, Eva Nabulime, Rose Nabatanzi, Alice Bayiyana, Francis Waswa, Brian Nyiro, Rebecca Nakaziba, Misaki Wayengera, Obondo James Sande, Alex Kayongo, Sharon Bright Amanya, Ashaba Fred Katabazi
Publikováno v:
Retrovirology
Retrovirology, Vol 17, Iss 1, Pp 1-11 (2020)
Retrovirology, Vol 17, Iss 1, Pp 1-11 (2020)
Background Tripartite Motif Containing 5 alpha (TRIM5α), a restriction factor produced ubiquitously in cells and tissues of the body plays an important role in the immune response against HIV. TRIM5α targets the HIV capsid for proteosomal destructi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b40731c7686788dfb4c2d284ffeaf200
https://doi.org/10.21203/rs.3.rs-26665/v1
https://doi.org/10.21203/rs.3.rs-26665/v1
Autor:
Peter Mugyenyi, Fred Kyeyune, Eva Nabulime, Miguel E. Quiñones-Mateu, Mariano Avino, Immaculate Nankya, Richard M. Gibson, Art F. Y. Poon, Eric J. Arts, Cissy Kityo, Emmanuel Ndashimye
Publikováno v:
AIDS research and human retroviruses, 34(5), 404-414. Mary Ann Liebert Inc.
To screen for drug resistance and possible treatment with Dolutegravir (DTG) in treatment-naive patients and those experiencing virologic failure during first-, second-, and third-line combined antiretroviral therapy (cART) in Uganda. Samples from 41
Autor:
Art F. Y. Poon, Eva Nabulime, Emmanuel Ndashimye, Abayomi S Olabode, Miguel E. Quiñones-Mateu, Mariano Avino, Immaculate Nankya, Fred Kyeyune, Richard M. Gibson, Adam Meadows, Daniel J. Lizotte, Cissy Kityo, Eric J. Arts
The global HIV-1 pandemic comprises many genetically divergent subtypes. Most of our understanding of drug resistance in HIV-1 derives from subtype B, which predominates in North America and western Europe. However, about 90% of the pandemic represen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c625128b393a9104521b028e9ca8defd
Autor:
Charles Drago Kato, Fred Kyeyune, Eva Nabulime, Immaculate Nankya, Pamela Ainembabazi, Alisen Ayitewala
Publikováno v:
AIDS Research and Therapy
AIDS Research and Therapy, Vol 17, Iss 1, Pp 1-9 (2020)
AIDS Research and Therapy, Vol 17, Iss 1, Pp 1-9 (2020)
BackgroundResistance to antiretroviral drugs is a major challenge among Human Immunodeficiency Virus (HIV) positive patients receiving antiretroviral therapy (ART). Mutations that arise as a result of this are diverse across the various drugs, drug c